The MTHFR 677C→T polymorphism and risk of prostate cancer: results from the CAPS study
✍ Scribed by Mattias Johansson; Bethany Van Guelpen; Johan Hultdin; Fredrik Wiklund; Hans-Olov Adami; Katarina Bälter; Henrik Grönberg; Pär Stattin
- Publisher
- Springer Netherlands
- Year
- 2007
- Tongue
- English
- Weight
- 209 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Methylenetetrahydrofolate reductase (MTHFR) is a vital enzyme catalyzing the nicotinamide adenine dinucleotide phosphate (NADPH) linked reduction of 5,10‐methylenetetrahydrofolate to 5‐methylenetetrahydrofolate, which serves as cofactor in methylation of homocysteine to methionine. Thre
## Abstract Etiological risk factors for proximal (right‐sided) colon cancers may be different to those of distal colon and rectal (left‐sided) cancers if these tumors develop along distinct pathways. The CpG Island Methylator Phenotype (CIMP+) occurs in approximately 15% of colorectal cancers (CRC